Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20101
20121
20141
20171
20182
20201
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Terminated3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neuroscience Trials Australia2
The George Institute2
University of Calgary2
Bayer1
Boehringer Ingelheim1
CSL Behring1
Forest Laboratories1
H. Lundbeck A/S1
Janssen Research & Development, LLC1
Joseph Broderick1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke15
Stroke11
Cardiovascular Diseases2
Cerebrovascular Disorders2
Hypertension2
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Brain Diseases1
Brain Infarction1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.